Sun Pharma Q2 profit takes a hit on exceptional items
Economic Times
Sun Pharmaceutical has seen a notable 36% drop in net profit, juxtaposed with an 11.8% rise in consolidated revenue. The uplift in revenue can be attributed largely to strong sales growth in India and emerging markets, particularly in domestic…
Summary from Economic Times
Read the full story on Economic TimesTimeline
- Economic Times first reported it
- NDTV Profit reported it
- The Hindu reported it
- Latest update
Follow
